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Abstract
This report highlights a conference designed for patient education on elevated cerebrospinal fluid
(CSF) pressure. The conference centered on chronic intracranial hypertension (IH) including the
latest research and clinical information. It was sponsored by the Intracranial Hypertension
Research Foundation and held at the University of Texas Medical School, Houston, on June 21–
22nd, 2008.
Background
The Intracranial Hypertension Research Foundation
(IHRF) in Vancouver, Washington, promotes research
into the pathophysiological basis of chronic IH and the
evolution of better treatment and, ultimately, a cure. IHRF
is a multi-functional organization. It not only encourages
research, but also facilitates understanding and manage-
ment of chronic primary and secondary IH, through
research, training and education programs worldwide.
IHRF sponsors programs for researchers and clinicians, as
well as educational conferences for patients and families.
The Houston conference was attended by 108 patients
and family members who heard presentations by nine cli-
nicians and researchers.
Patients asked many questions during extensive panel ses-
sions. The conference also allowed patients to speak about
personal experiences with the disorder. IHRF held the first
conference on chronic IH in 2006 at the Oregon Health &
Science University (OHSU). A wide variety of subjects
were presented to enhance patient knowledge and aware-
ness. Patient education importantly improves patient
insight about the disorder. It also facilitates active cooper-
ation with their physicians. Understanding limitations of
accepted medical and surgical treatment leads to realistic
goals in management.
Additionally, patient education is vital in controlling
health care costs.
Discussion
The opening presentation by Conrad Johanson, Professor
of Clinical Neuroscience at Brown University dealt with
CSF production in the choroid plexus and its possible role
in IH. Covered in the lecture was the structure of the
choroid plexus, the dynamic turnover of ions and water in
CSF production by the choroidal epithelium, the trans-
port of CSF solute for the brain, and homeostasis of CNS
extracellular fluid. A discussion of translational research
goals involving the choroid plexus and CSF and possible
directions for research in IH concluded the presentation.
John McGregor, Associate Professor of Neurosurgery at
Ohio State University, spoke on "Neural Hydrodynamics
Disorders: Hydrocephalus, Intracranial Hypertension and
the Chiari Malformation. Relationships, Similarities and
Differences" which was followed by two lectures covering
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tions discussed in depth the available technology with
details of the features of each device.
The conclusion was that despite the numerous designs,
the overall success rate for the various shunts and valve
equipment are similar. Better designed shunts are greatly
needed.
The next lecture by Conrad Johanson: "Current Theories
on Causation and Reduction of Elevated CSF Pressures:
Implications for Intracranial Hypertension", began with a
discussion of CSF fluid dynamics centering on CSF reab-
sorption including the controversial arachnoid and CSF
lymphatic drainage. The role of neuropeptides such as
atrial natriuretic peptide (ANP) in CSF production and the
role of growth factors like basic fibroblast growth factor
(FGF2) in CSF reabsorption, were identified. The intrigu-
ing possibility of peptides as pharmacological agents in
controlling intracranial pressure (ICP) was thought pro-
voking and stimulating, especially since no specific drug is
available to control production and egress of CSF.
Steven Katz, neuro-ophthalmologist and Associate Profes-
sor of Ophthalmology at Ohio State University, lectured
on the symptoms and signs in idiopathic intracranial
hypertension (IIH) and the medical management
options. He discussed approaches that work best in his
practice. Steven Katz had previously demonstrated the
somatostatin receptors 1 and 2 in normal human choroid
plexus and arachnoid granulations and thus surmised that
somatostatin is involved in CSF production and egress.
His preliminary clinical use of octreotide, a peptide that
mimics somatostatin, was discussed, including the poten-
tial complications of somatosatin analogs to control IH.
Steven Katz described his techniques for optic nerve
sheath decompression and demonstrated findings from
many of his procedures. He attributed excellent outcomes
to reduced surgery duration, i.e. especially the time of
optic nerve stretching. He emphasized that short exposure
and optimal surgical approach lead to minimal diplopia,
ptosis and most importantly, minimal vision loss.
Marc Criden, neuro-ophthalmologist and Assistant Pro-
fessor of Ophthalmology at the University of Texas, Hou-
ston, presented an updated overview of pediatric IH. In
children under 10 years, gender and weight are not the
factors they are in adults. He pointed out that many phy-
sicians consider IH in children under 10 to be a different
disorder because of these characteristic differences. Head-
aches associated with IH and how best to manage them
were discussed by neurologist and neuro-ophthalmolo-
gist, Leonard Hershkowitz of Baylor University. He indi-
cated his management techniques that worked well for
him.
A reception followed in which patients again communi-
cated with the speakers.
The 2nd conference day opened with a discussion of the
mission and goals of IHRF and a review of IHRF-spon-
sored research by Emanuel Tanne, Clinical Assistant Pro-
fessor of Ophthalmology, OHSU and president of IHRF.
He pointed out that IHRF works to remove significant
obstacles to research: under-funding, under-coordination
of effort, incomplete recognition of the life-altering effects
of IIH, and low recruitment of researchers in this area.
IHRF funded animal model development projects at the
University of Chicago and the University of Arkansas.
Under investigation is a knockout mouse that develops IH
shortly after weaning. Other research areas included joint
testing at the University of Utah of a NASA-developed,
non-invasive, closed loop ultrasound device to measure
ICP in microgravity and an investigation of vitamin A
receptors in arachnoid granulations at Ohio State Univer-
sity. IHRF also partners with the Casey Eye
Institute, in regard to the Intracranial Hypertension Regis-
try at the Oregon Health & Science University, Portland.
The IH Registry is a relational database management sys-
tem designed for medical research. Emanuel Tanne dis-
cussed ongoing Registry research, including studies in
genetics, economics, weight gain and pregnancy. Jessica
Tanne, IHRF Director, Communications & Development,
discussed raising community awareness, fundraising and
the importance of becoming an IH ambassador. Illustrat-
ing and discussing their fundraising creativity were Dori
Clements and Jacque Tate, both parents of IH children.
Clark Sitton, Assistant Professor of Radiology, University
of Texas, Houston, discussed types of imaging studies and
the goals of imaging in IH. He presented an extensive col-
lection of studies demonstrating pathological findings
associated with IH.
Bariatric surgery as a possible option in the management
of IH was presented by Erik Wilson, Assistant Professor of
Surgery, University of Texas, Houston, who covered risks
and benefits of bariatric surgery, using his extensive expe-
rience as a guide. He also discussed types of procedures
available and his personal approach to follow-up and
long term goals for patients. Marc Criden presented a new
hypothesis to consider for clinical management of chronic
IH: establishing target pressures for each patient with IH.
The hypothesis arose out of his and Steven Katz's experi-
ence with patients at the last IHRF patient conference,
where they were impressed by the variety of symptoms
and patient reports contradictory to current teaching.
They hypothesized that chronically elevated ICP is neuro-
logically damaging, even in patients without significant
visual dysfunction or intractable headache. They are pres-Page 2 of 3
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ently investigating and evaluating this hypothesis. The
final speaker, Kapil Kapoor, resident in ophthalmology at
the University of Texas, Galveston, presented his research
on hyposmia and IH. He found that patients with elevated
ICP have a decreased sense of smell and concluded that
other nerves such as the olfactory nerve may be function-
ally compromised in the setting of IH by a mechanism
similar to that of optic nerve compression. Therefore, it
may be appropriate to consider IH as a more global neu-
roanatomic insult of augmented CSF pressure than previ-
ously considered.
Conclusion
While the intent of educating patients was admirably
accomplished by this conference, the conference served as
a unique experience for researchers and clinicians to hear
from a large group of patients about the nature of their
disorders. Therefore, not only did physicians from a vari-
ety of sub-specialties have an opportunity to exchange
ideas and explore future collaborative projects they also
left with a different perspective of chronic IH and a new
appreciation of patient-centered conferences as a mecha-
nism to expedite translational CSF research.
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